Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasocitinib in Dry Eye Disease
NCT01226680Phase 2Withdrawn
- Sponsor
- Pfizer
- Start
- Dec 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tofacitinib in dry eye disease (DED), sponsored by Pfizer. Planned start Dec 2010; status: withdrawn.
02
Drugs
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT01226680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226680.